Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Caxton Advantage Life Sciences Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 14
Average round size
info
The average size of a deal this fund participated in
$42M
Portfolio companies 7
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Exits 6
Key employees 1
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Pharmaceutical
  • Therapeutic Devices

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Caxton Advantage Life Sciences Fund:
Typical Co-investors
Caxton Advantage Life Sciences Fund is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Caxton Advantage Life Sciences Fund:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Azure Redmond, United States, Washington
Bright Success Capital China, Hong Kong, Hong Kong Island
DT&I -
FamilySearch Salt Lake City, United States, Utah
Five Seasons Ventures France, Ile-de-France, Paris
InnoSpring Seed Fund California, Palo Alto, United States
K2 Investment Partners Seoul, Seoul-t'ukpyolsi, South Korea
KP Engineering Texas, Tyler, United States
LongeVC Lugano, Switzerland, Ticino
RCM Business Bhilwara, India, Rajasthan
Riceland HealthCare Texas, United States, Winnie
Sarissa Capital Management -
Singh Capital Partners Maryland, Potomac, United States
TechnoStart Germany, Ludwigsburg, Mecklenburg-Vorpommern
TF1 Group Boulogne, France, Nord-Pas-de-Calais
The Westly Group California, Menlo Park, United States
Travel Capitalist Ventures (USA, S Africa, Mideast, India) California, Irvine, United States
UHT Investments Dubai, United Arab Emirates

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Gemin X Pharmaceuticals

Biotechnology
Pharmaceutical
Therapeutics
$38M03 Jul 2008 Montreal, Quebec, Canada

Corthera

Biotechnology
Health Care
Therapeutics
$23M20 Dec 2007 California, United States

Mevion Medical Systems

Biotechnology
Health Care
Therapeutic Devices
Therapeutics
$6M08 Oct 2007 Massachusetts, United States

Regado Biosciences

Biotechnology
Health Care
Therapeutics
$23M27 Mar 2007 Durham, North Carolina, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Caxton Advantage Life Sciences Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 14
Average round size 42M
Peak activity year 2009
Lead investments 3
Follow on index 0.50
Exits 6
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Gemin X Pharmaceuticals

Biotechnology
Pharmaceutical
Therapeutics
$38M03 Jul 2008 Montreal, Quebec, Canada

Corthera

Biotechnology
Health Care
Therapeutics
$23M20 Dec 2007 California, United States

Mevion Medical Systems

Biotechnology
Health Care
Therapeutic Devices
Therapeutics
$6M08 Oct 2007 Massachusetts, United States

Regado Biosciences

Biotechnology
Health Care
Therapeutics
$23M27 Mar 2007 Durham, North Carolina, United States
Crunchbase icon

Content report

The following text will be sent to our editors: